Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Tourmaline Bio Reports Pricing Of Public Offering Of 4.61M Shares Of Its Common Stock At $32.50 Per Share

Author: Benzinga Newsdesk | January 25, 2024 08:11am

The gross proceeds to Tourmaline from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $150.0 million. The offering is expected to close on January 29, 2024, subject to satisfaction of customary closing conditions.

Posted In: TRML